NCT02347839 2024-12-10
NEGOTIATE
Sun Yat-sen University
Phase 2 Withdrawn
Clinical Trials
9 trialsNCT03529084 2019-11-22
Phase III Study of Nazartinib (EGF816) Versus Erlotinib/Gefitinib in First-line Locally Advanced / Metastatic NSCLC With EGFR Activating Mutations
Novartis
Phase 3 Withdrawn
NCT00268255 2013-04-16
Gefitinib and Radiation Therapy in Treating Patients With Inoperable Stage I or Stage II Non-Small Cell Lung Cancer
Barbara Ann Karmanos Cancer Institute
Phase 1/2 Withdrawn
NCT00090675 2013-01-29
IMAC/Herbst
AstraZeneca
Phase 3 Withdrawn
NCT00098462 2012-10-04
Gefitinib and Sirolimus in Treating Patients With Recurrent or Refractory Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Jonsson Comprehensive Cancer Center
Phase 1/2 Withdrawn
NCT00048087 2012-07-31
Iressa/Docetaxel in Non-Small-Cell Lung Cancer
M.D. Anderson Cancer Center
Phase 2 Withdrawn
NCT00252811 2011-01-28
A Study of ZD1839 Effects on Cell Proliferation in Breast Cancer
AstraZeneca
Phase 2 Withdrawn
NCT00233623 2011-01-27
Irinotecan, 5-Fluorouracil and Leucovorin With or Without Iressa in the Treatment of Metastatic Colorectal Cancer
AstraZeneca
Phase 2 Withdrawn
NCT00233636 2011-01-27
Iressa and Radiotherapy in the Treatment of the Locally Advanced Inoperable Squamous Cell Carcinoma of the Head and Neck
AstraZeneca
Phase 2 Withdrawn